Matthew Gline - Net Worth and Insider Trading
Matthew Gline Net Worth
The estimated net worth of Matthew Gline is at least $220 Million dollars as of 2024-11-29. Matthew Gline is the CEO of Roivant Sciences Ltd and owns about 17,372,004 shares of Roivant Sciences Ltd (ROIV) stock worth over $220 Million. Details can be seen in Matthew Gline's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Gline has not made any transactions after 2024-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew Gline
Matthew Gline Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew Gline owns 1 companies in total, including Roivant Sciences Ltd (ROIV) .
Click here to see the complete history of Matthew Gline’s form 4 insider trades.
Insider Ownership Summary of Matthew Gline
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2024-09-23 | director & CEO |
Matthew Gline Latest Holdings Summary
Matthew Gline currently owns a total of 1 stock. Matthew Gline owns 17,372,004 shares of Roivant Sciences Ltd (ROIV) as of September 23, 2024, with a value of $220 Million.
Latest Holdings of Matthew Gline
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2024-09-23 | 17,372,004 | 12.69 | 220,450,731 |
Holding Weightings of Matthew Gline
Matthew Gline Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew Gline has made a total of 12 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 1,983,257 shares on September 23, 2024, which brought Matthew Gline around $23 Million.
Insider Trading History of Matthew Gline
- 1
Matthew Gline Trading Performance
Matthew Gline Ownership Network
Matthew Gline Owned Company Details
What does Roivant Sciences Ltd do?
Who are the key executives at Roivant Sciences Ltd?
Matthew Gline is the director & CEO of Roivant Sciences Ltd. Other key executives at Roivant Sciences Ltd include President & COO Eric Venker , 10 percent owner & other: Director by Deputization Qvt Financial Lp , and Chief Accounting Officer Rakhi Kumar .
Roivant Sciences Ltd (ROIV) Insider Trades Summary
Over the past 18 months, Matthew Gline made 1 insider transaction in Roivant Sciences Ltd (ROIV) with a net sale of 1,983,257. Other recent insider transactions involving Roivant Sciences Ltd (ROIV) include a net sale of 3,296,535 shares made by Eric Venker , a net sale of 399,619 shares made by Rakhi Kumar , and a net sale of 14,426,000 shares made by Daniel Allen Gold .
In summary, during the past 3 months, insiders sold 8,288,257 shares of Roivant Sciences Ltd (ROIV) in total and bought 0 shares, with a net sale of 8,288,257 shares. During the past 18 months, 89,546,832 shares of Roivant Sciences Ltd (ROIV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 89,546,832 shares.
Roivant Sciences Ltd (ROIV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Roivant Sciences Ltd Insider Transactions
Matthew Gline Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew Gline. You might contact Matthew Gline via mailing address: C/o Urovant Sciences, Inc., 5151 California Avenue, Suite 250, Irvine Ca 92617.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
